| Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients J Li, S Liu, Q Fu, Y Zhang, X Wang, X Liu, L Liu, C Wang, M Huang Pharmacogenomics 16 (12), 1355-1365, 2015 | 55 | 2015 |
| Association of p53 rs1042522, MDM2 rs2279744 and p21 rs1801270 polymorphisms with retinoblastoma risk and invasion in a Chinese population R Chen, S Liu, H Ye, J Li, Y Du, L Chen, X Liu, Y Ding, Q Li, Y Mao, S Ai, ... Scientific reports 5 (1), 13300, 2015 | 38 | 2015 |
| The POR rs1057868–rs2868177 GC-GT diplotype is associated with high tacrolimus concentrations in early post-renal transplant recipients S Liu, R Chen, J Li, Y Zhang, X Wang, Q Fu, L Chen, X Liu, H Huang, ... Acta Pharmacologica Sinica 37 (9), 1251-1258, 2016 | 17 | 2016 |
| Wnt receptor gene FZD1 was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort X Liu, SK Low, JR Atkins, JQ Wu, WR Reay, HM Cairns, MJ Green, ... Australian & New Zealand Journal of Psychiatry 54 (9), 902-908, 2020 | 12 | 2020 |
| Clinical pharmacokinetic and Pharmacodynamic considerations in the (modern) treatment of melanoma HY Kim, PJ Upadhyay, A Fahmy, X Liu, JK Duong, AV Boddy Clinical Pharmacokinetics 58, 1029-1043, 2019 | 9 | 2019 |
| Pharmacokinetics of dabrafenib in a patient with metastatic melanoma undergoing haemodialysis JJ Park, AV Boddy, X Liu, D Harris, V Lee, RF Kefford, MS Carlino Pigment Cell & Melanoma Research 30 (1), 68-71, 2017 | 9 | 2017 |
| Associations of HSD11B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients with prednisone combined therapy X Liu, J Li, Q Fu, S Liu, Y Zhang, X Wang, H Wang, J Li, C Zhu, C Wang, ... Drug Metabolism and Disposition 43 (4), 455-458, 2015 | 8 | 2015 |
| The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors X Liu, SK Low, AV Boddy Expert opinion on drug metabolism & toxicology 12 (8), 851-863, 2016 | 4 | 2016 |
| The path to implementation of personalized medicine of aromatase inhibitors in patients with breast cancer X Liu, J Beith, SK Low, AV Boddy Pharmacogenomics 17 (17), 1861-1864, 2016 | | 2016 |
